The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT in prostate carcinoma

被引：0
|
作者：
Aijuan Tian
Runlong Lin
Jing Yu
Fan Zhang
Qiang Zheng
Xin Yuan
Zhanhua Sun
Zhaoyan Zhong
机构：
[1] The Second Hospital of Dalian Medical University,Department of Nuclear Medicine
来源：
Prostate Cancer and Prostatic Diseases | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 358
页数：7
相关论文
共 50 条
  • [31] PROSPECTIVE EVALUATION OF 18F-DCFPYL PET/CT IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: ANALYSIS OF 18F-DCFPYL UPTAKE IN POSSIBLE EXTRA-PELVIC OLIGOMETASTASES
    Song, Hong
    Nguyen, Judy
    Moradi, Farshad
    Aparici, Carina Mari
    Franc, Ben
    Davidzon, Guido
    Iagaru, Andrei
    JOURNAL OF UROLOGY, 2021, 206 : E1177 - E1178
  • [32] FDA Approves 18F-DCFPyL PET Agent in Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 11N - 11N
  • [33] Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer
    Voter, Andrew F.
    Werner, Rudolf A.
    Pienta, Kenneth J.
    Gorin, Michael A.
    Pomper, Martin G.
    Solnes, Lilja B.
    Rowe, Steven P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (07) : 681 - 694
  • [34] A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY).
    Morris, Michael J.
    Carroll, Peter
    Probst, Stephan
    Pouliot, Frederic
    Saperstein, Lawrence
    Siegel, Barry A.
    Alva, Ajjai Shivaram
    Preston, Mark A.
    Patnaik, Akash
    Gorin, Michael A.
    Durack, Jeremy C.
    Nichols, Melissa
    Lin, Tess
    Strack, Thomas
    DiPippo, Vincent A.
    Jensen, Jessica Donato
    Mahmood, Syed
    Wong, Vivien
    Pienta, Kenneth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] The effect of uptake time on 18F-DCFPyL PSMA PET/CT maximum standardised uptake value
    Nassour, Anthony-Joe
    Jain, Anika
    Thompson, Nadine
    Khanani, Hadia
    Tarlinton, Lisa
    Sorensen, Brian
    Bergersen, Philip
    Dias, Max
    Chalasani, Venu
    Baskaranathan, Sris
    Symons, James
    Wines, Michael
    Woo, Henry
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 21 - 21
  • [36] Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma
    Rowe, Steven P.
    Gorin, Michael A.
    Hammers, Hans J.
    Pomper, Martin G.
    Allaf, Mohammad E.
    Javadi, Mehrbod Som
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (01) : 83 - 85
  • [37] Evaluation of Equivocal findings on 18F-DCFPyL PET/CT for Metastatic or Biochemically Recurrent Prostate Cancer
    Novello, M.
    Cengiz, T.
    Trak, J.
    Ghesani, M.
    Gavane, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S499 - S499
  • [38] A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
    Rousseau, Etienne
    Wilson, Don
    Lacroix-Poisson, Frederic
    Krauze, Andra
    Chi, Kim
    Gleave, Martin
    McKenzie, Michael
    Tyldesley, Scott
    Goldenberg, S. Larry
    Benard, Francxois
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 1587 - 1593
  • [39] Overcoming challenges associated with 18F-DCFPyL PET imaging in prostate cancer
    Arachchige, Arosh S. Perera Molligoda
    CANADIAN JOURNAL OF UROLOGY, 2023, 30 (02)
  • [40] To access the clinical value of combined 18F-FDG and 18F-DCFPyL PET/CT in postoperative recurrent or metastasis renal cell carcinoma
    Wang, Guanyun
    Liu, Yachao
    Ning, Jing
    Lin, Mu
    Wu, Yue
    Xu, Baixuan
    Gao, Jiangping
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345